Synthes Confirms Potential $20B Acquisition By J&J
Synthes Inc. confirmed Monday that it is in talks with New Jersey-based medical device giant Johnson & Johnson about a merger that could value the Swiss-based medical device maker at $20...To view the full article, register now.
Already a subscriber? Click here to view full article